Status:
NOT_YET_RECRUITING
Biochemical Role of Matrix Metalloproteinase -9 in Rheumatoid Arthritis
Lead Sponsor:
Sohag University
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
15-90 years
Phase:
NA
Brief Summary
Rheumatoid arthritis (RA) is a systemic autoimmune pathology associated with a chronic inflammatory process, which can damage both joints and extra-articular organs, including the heart, kidney, lung,...
Eligibility Criteria
Inclusion
- patients with rheumatoid arthritis who fulfilled the EULAR/ACR Criteria 2010 for the Classification of RA .. All patients recruited for the study had active RA confirmed by assessment of activity by DAS28 .
Exclusion
- No patient had a history of tuberculosis or symptoms of infectious diseases in the previous 3 months.
- 2-30 healthy subjects; age and sex mateched to the patients as healthy controls.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06494813
Start Date
August 1 2024
End Date
December 15 2024
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University hospitals
Sohag, Egypt